JCO oncology practice
Characterizing Patient-Reported Outcome Data Availability for Oral Anticancer Therapies.
Britny R Brown, Jessica Samuel, Morgan Teeters, Ami Vyas, John Bossaer
Published: 202510.1200/OP-25-00770
Abstract
PURPOSE: Since the first oncology-specific US Food and Drug Administration (FDA) guidance on patient-reported outcomes (PROs) was released in 2016, substantial progress has been made in integrating PROs into clinical trials. Nonetheless, PRO data for…
Preview only. Read the full abstract at the source